This project will overcome the current limitations of conventional CT imaging dedicated to cardiovascular disease (CVD) by developing a non-radioactive molecular imaging methodology using the SPCCT technology. This will be achievable with a high spatial resolution of 200 µm combined with newly developed contrast agents detected with high quality K-edge technique that can only be provided by SPCCT technology.
The project will overcome the current limitations of conventional CT imaging dedicated to cardiovascular disease by developing a non-radioactive molecular imaging methodology using SPCCT technology
The specific objectives of the ATHERSPECTRAL-CT project are:
Source :
https://anr.fr/Project-ANR-17-CE19-0018
Ce site utilise des cookies pour vous offrir le meilleur service. Vous pouvez cependant choisir de ne pas les utiliser en validant votre choix ci-dessous. Pour en savoir plus sur l'utilisation de cookies sur ce site, vous pouvez cliquer ici.